SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy

Lulu Han,Yi Zheng,Jian Deng,Mei‐Ling Nan,Yang Xiao,Meng‐Wei Zhuang,Jing Zhang,Wei Wang,Chengjiang Gao,Pei‐Hui Wang

DOI: https://doi.org/10.1002/jmv.27965

IF: 20.693

2022-06-30

Journal of Medical Virology

Abstract:A characteristic feature of COVID‐19, the disease caused by SARS‐CoV‐2 infection, is the dysregulated immune response with impaired type I and III interferon (IFN) expression and an overwhelming inflammatory cytokine storm. RIG‐I‐like receptors (RLRs) and cGAS‐STING signaling pathways are responsible for sensing viral infection and inducing IFN production to combat invading viruses. Multiple proteins of SARS‐CoV‐2 have been reported to modulate the RLR signaling pathways to achieve immune evasion. Although SARS‐CoV‐2 infection also activates the cGAS‐STING signaling by stimulating micronuclei formation during the process of syncytia, whether SARS‐CoV‐2 modulates the cGAS‐STING pathway requires further investigation. Here, we screened 29 SARS‐CoV‐2‐encoded viral proteins to explore the viral proteins that affect the cGAS‐STING signaling pathway and found that SARS‐CoV‐2 ORF10 targets STING to antagonize IFN activation. Overexpression of ORF10 inhibits cGAS‐STING‐induced IRF3 phosphorylation, translocation, and subsequent IFN induction. Mechanistically, ORF10 interacts with STING, attenuates the STING‐TBK1 association, and impairs STING oligomerization and aggregation and STING‐mediated autophagy; ORF10 also prevents the endoplasmic reticulum (ER)‐to‐Golgi trafficking of STING by anchoring STING in the ER. Taken together, these findings suggest that SARS‐CoV‐2 ORF10 impairs the cGAS‐STING signaling by blocking the translocation of STING and the interaction between STING and TBK1 to antagonize innate antiviral immunity.This article is protected by copyright. All rights reserved.

virology